Heidi Sullivan, NP
Family · Savannah, GANPI 1295188498
Payments from drug & device makers
Across 144 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$470
- AbbVie$407
- Novo Nordisk$405
- AstraZeneca$225
- Amgen$202
- Boehringer Ingelheim$194
- plus $561 from 14 others
What the payments were for
- Food & beverage$2,43199%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 27 | $470 |
| AbbVie | 24 | $407 |
| Novo Nordisk | 28 | $405 |
| AstraZeneca | 13 | $225 |
| Amgen | 11 | $202 |
| Boehringer Ingelheim | 9 | $194 |
| Pfizer | 6 | $103 |
| GSK | 4 | $92 |
| Exact Sciences | 5 | $72 |
| Sanofi-aventis U.S. LLC | 4 | $69 |
| Phathom Pharmaceuticals, Inc. | 3 | $49 |
| Esperion Therapeutics, Inc. | 2 | $28 |
| Novartis | 1 | $24 |
| Baxter Healthcare | 1 | $23 |
| Merck | 1 | $20 |
| Antares Pharma, Inc. | 1 | $19 |
| Bayer | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
How this compares
$2,463 in reported general payments places this provider in the 80th percentile of 6,258 family providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 38 | $45,237 |
| FarxigaDapagliflozin Propanediol | 39 | $42,718 |
| TrulicityDulaglutide | 35 | $40,991 |
| MounjaroTirzepatide | 11 | $17,779 |
| EliquisApixaban | 16 | $16,034 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $15,049 |
| JardianceEmpagliflozin | 13 | $14,952 |
| NexletolBempedoic Acid | 12 | $4,579 |
| SynthroidLevothyroxine Sodium | 20 | $1,781 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 51 | $1,397 |
| Rosuvastatin Calcium | 122 | $1,240 |
| Gabapentin | 53 | $1,203 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $1,132 |
| Levothyroxine Sodium | 123 | $1,027 |
| Atorvastatin Calcium | 101 | $869 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $470 | $58,77046 claims |
| Novo NordiskOzempic | $405 | $45,23738 claims |
| AstraZenecaFarxiga | $225 | $42,71839 claims |
| PfizerEliquis | $103 | $16,03416 claims |
| GSKTrelegy Ellipta | $92 | $15,04923 claims |
| Boehringer IngelheimJardiance | $194 | $14,95213 claims |
| Esperion Therapeutics, Inc.Nexletol | $28 | $4,57912 claims |
| AbbVieSynthroid | $407 | $1,78120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,258 family providers in Georgia.
Other family in Savannah
- Kaitlyn BuchananSavannah$24K
- Shelby CallowaySavannah$16K
- Erin RedmondSavannah$15K
- Caroline SauersSavannah$14K
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.